<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Adare Pharmaceuticals, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=24626></link><description><![CDATA[Adare Pharmaceuticals, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sun, 03 May 2026 00:54:54 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2015/04/12_3554153577_20150403134656_1122925626.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Adare Pharmaceuticals Appoints Dr. Peter Richardson as Vice President, Research & Development and Chief Medical Officer]]></title><link>https://www.newswire.co.kr/newsRead.php?no=839376</link><description><![CDATA[PRINCETON, N.J.--(Business Wire/Korea Newswire)--Adare Pharmaceuticals, Inc. announced that Dr. Peter Richardson has joined the Company as Vice President, Research &amp; Development and Chief Medical Officer. Dr. Richardson will be responsible for leading our Research and Development efforts worldwide and for the successful development of the Company’s pipeline.  “We are delighted to have Pete...]]></description><pubDate>Wed, 09 Nov 2016 15:50:00 +0900</pubDate></item><item><title><![CDATA[어데어 제약, 연구개발 부사장 겸 최고의료책임자에 피터 리처드슨 박사 임명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=839377</link><description><![CDATA[프린스턴, 뉴저지--(Business Wire/뉴스와이어)--어데어 제약(Adare Pharmaceuticals, Inc.)이 피터 리처드슨(Peter Richardson) 박사가 연구개발 부사장 겸 최고의료책임자(Chief Medical Officer)로 회사에 합류한다고 밝혔다. 리처드슨 박사는 전세계 연구개발 업무와 회사 파이프라인의 성공적인 개발을 책임지게 된다.  존 프라허(John Fraher) 어데어 제약 사장 겸 최고경영자(CEO)는 “피터가 어데어에 합류하게 되어...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2016/11/3698601005_20161109154923_1469373874.jpg]]></url></image><pubDate>Wed, 09 Nov 2016 15:50:00 +0900</pubDate></item><item><title><![CDATA[Adare Pharmaceuticals Appoints James Jogerst as Vice President, Corporate Development]]></title><link>https://www.newswire.co.kr/newsRead.php?no=806927</link><description><![CDATA[PRINCETON, N.J.--(Business Wire/Korea Newswire)--Adare Pharmaceuticals, Inc. announced today that James (Jim) Jogerst has joined the Company as Vice President, Corporate Development. He will be based at the Company’s headquarters in Princeton, NJ.  “We are delighted to have Jim join the Adare team. His extensive global experience in the areas of corporate development and M&amp;A within the pha...]]></description><pubDate>Tue, 20 Oct 2015 14:40:00 +0900</pubDate></item><item><title><![CDATA[어데어제약, 그룹 기획 부사장에 제임스 조거스트 임명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=806928</link><description><![CDATA[프린스턴, 뉴저지--(Business Wire/뉴스와이어)--제임스(짐) 조거스트(James (Jim) Jogerst)가 어데어제약(Adare Pharmaceuticals, Inc.) 그룹기획 부사장으로 회사에 합류한다고 어데어제약이 오늘 발표했다. 조거스트는 미국 뉴저지주 프린스턴에 위치한 그룹 본사에서 근무하게 된다.   존 프라허(John Fraher) 어데어제약 사장/CEO는 “짐을 한 식구로 맞이하게 돼 기쁘다”고 말했다. 프라허 사장은 “그는 제약 및 의료...]]></description><pubDate>Tue, 20 Oct 2015 14:40:00 +0900</pubDate></item><item><title><![CDATA[Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer]]></title><link>https://www.newswire.co.kr/newsRead.php?no=801594</link><description><![CDATA[PRINCETON, N.J.--(Business Wire/Korea Newswire)--Adare Pharmaceuticals, Inc., formerly Aptalis Pharmaceutical Technologies, announced today that Joseph (Joe) Del Buono has joined the Company as Vice President, Finance and Chief Financial Officer. He will be based at the Company’s headquarters in Princeton, NJ.  “We are pleased to have Joe join our team as our CFO. His extensive background in p...]]></description><pubDate>Wed, 26 Aug 2015 21:30:00 +0900</pubDate></item><item><title><![CDATA[어데어 제약, 재무부사장 겸 최고재무책임자에 조셉 델 부오노 임명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=801595</link><description><![CDATA[프린스턴, 뉴저지--(Business Wire/뉴스와이어)--어데어 제약(Adare Pharmaceuticals, Inc., 구 앱탈리스 파마슈티컬 테크놀로지스(Aptalis Pharmaceutical Technologies))가 오늘 회사의 재무부사장 겸 최고재무책임자(CFO)에 조셉 델 부오노(Joseph Del Buono)를 임명했다고 발표했다.  존 프라허(John Fraher) 어데어 제약 사장 겸 최고경영자(CEO)는 “조셉이 CFO로 우리 팀에 합류하게 되어 기쁘다”며 “제약회사 재무 ...]]></description><pubDate>Wed, 26 Aug 2015 21:30:00 +0900</pubDate></item><item><title><![CDATA[TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals]]></title><link>https://www.newswire.co.kr/newsRead.php?no=787852</link><description><![CDATA[BRIDGEWATER, N.J. & FORT WORTH, Texas--(Business Wire/Korea Newswire)--Aptalis Pharmaceutical Technologies announced today that its divestiture from Actavis plc to TPG, a global private investment firm, has been completed. The company also announced that its new name is Adare Pharmaceuticals and John Fraher, who was president of Aptalis Pharmaceutical Technologies, has been named the CEO. He is joined by key execut...]]></description><pubDate>Fri, 03 Apr 2015 13:50:00 +0900</pubDate></item><item><title><![CDATA[TPG, 앱탈리스 파마슈티컬테크놀로지스 인수 매듭…어데어제약으로 사명 변경]]></title><link>https://www.newswire.co.kr/newsRead.php?no=787853</link><description><![CDATA[브리지워터, 뉴저지 및 포트워스, 텍사스--(Business Wire/뉴스와이어)--앱탈리스 파마슈티컬 테크놀로지스(Aptalis Pharmaceutical Technologies)가 액타비스(Actavis plc)에서 분할돼 글로벌 사모투자 회사인 TPG에 매각됐다. 앱탈리스측은 자사의 분할 절차가 최종 완료됐다고 오늘 발표했다. 앱탈리스는 분할매각과 함께 사명을 어데어제약(Adare Pharmaceuticals)으로 변경했으며 앱탈리스 사장이었던 존 프라허(John Fraher)를 최고경영자(C...]]></description><pubDate>Fri, 03 Apr 2015 13:50:00 +0900</pubDate></item></channel></rss>